Diagnostics News and Research

RSS

Biosign grants 3,115,000 stock options at $0.92 per share

Biosign Technologies Inc. announced today the grant of an aggregate of 3,115,000 stock options pursuant to the Company's stock option plan. An aggregate of 1,115,000 of such options were granted effective June 16, 2011 to four directors of the Company.

23 Jun 2011

Veredus Labs develops ‘Lab-on-Chip’ to detect and differentiate several food-borne pathogens, including Escherichia coli

Veredus Laboratories, a leading provider of molecular detection tests, and its technology partner, STMicroelectronics (NYSE: STM), today announced the successful development and deployment of VereFoodborne™, a Lab-on-Chip application that is able to detect 10 to 12 food-borne pathogens in one test, including the Shiga toxin-producing Escherichia coli (E. coli) responsible for the recent severe food poisoning outbreak in Europe.

23 Jun 2011

Veredus Lab-on-Chip application can diagnose and differentiate food-borne pathogens

Veredus Laboratories, a leading provider of molecular detection tests, and its technology partner, STMicroelectronics, today announced the successful development and deployment of VereFoodborne, a Lab-on-Chip application that is able to detect 10 to 12 food-borne pathogens in one test, including the Shiga toxin-producing Escherichia coli responsible for the recent severe food poisoning outbreak in Europe.

23 Jun 2011

PNAS publishes Roche manuscript on generation of human bispecific IgG antibodies

The Roche manuscript: "Immunoglobulin Domain Crossover as a Generic Approach for the Production of Bispecific IgG Antibodies" has been published in the prestigious Proceedings of the National Academy of Sciences of the USA.

23 Jun 2011

Avedro receives Gold MDEA award for Vedera System

Avedro, Inc. announced today that the Vedera System for performing Keraflex has received the prestigious Gold level 2011 Medical Design Excellence Award.

22 Jun 2011

Biotest, Abbott partner to develop and commercialize BT-061 for autoimmune diseases

Abbott and Biotest AG today announced a global agreement to develop and commercialize BT-061, a novel anti-CD4 antibody for the treatment of rheumatoid arthritis (RA) and psoriasis.

22 Jun 2011

NextGen launches first CSF multiplex protein assay for detecting CNS diseases

NextGen Group plc is pleased to announce that its US-subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement and qualification, has launched its first cerebrospinal fluid (CSF) multiple protein assay, csfdiscovery43, for central nervous system (CNS) biomarker discovery and qualification.

21 Jun 2011

African-Americans more likely to die from thyroid cancer than whites

African-Americans have fewer incidences of thyroid cancer but have a more advanced form of the disease once they receive a diagnosis — and are more likely to die from it, according to a new study.

21 Jun 2011

Rheonix, Mayo Clinic partner for genotyping test to assist warfarin sensitivity

Mayo Clinic today announced that it has reached an agreement with Rheonix, Inc. to collaborate on the performance of a genotyping test for warfarin sensitivity in clinical and research settings.

21 Jun 2011

Mayo Clinic announces collaboration on genotyping test for Warfarin sensitivity

Mayo Clinic today announced that it has reached an agreement with Rheonix, Inc. to collaborate on the performance of a genotyping test for warfarin sensitivity in clinical and research settings. The genotyping test will be available for all patients of Mayo Clinic and is the subject of ongoing research for improved anticoagulation therapy. Additionally, the test will be offered through Mayo Clinic’s reference laboratory, Mayo Medical Laboratories, to clients throughout the world.

20 Jun 2011

Endo acquires American Medical Systems for $2.9 billion in cash

Endo Pharmaceuticals announced today the completion of its acquisition of American Medical Systems, Inc. (AMS). Endo announced on April 11, 2011, that it entered into a definitive agreement to acquire AMS, a leading provider of world-class devices and therapies for male and female pelvic health, for approximately $2.9 billion in cash.

20 Jun 2011

Genetic Technologies introduces BREVAGen genetic test for assessing non-familial breast cancer risk

Genetic Technologies Limited, through its North American division, Phenogen Sciences Inc., has launched the new BREVAGen genetic test for assessing non-familial breast cancer risk.

20 Jun 2011

Neogen announces acquisition of VeroMara

Neogen Corporation announced today that it has acquired the assets of the VeroMara seafood testing laboratory from its parent company, GlycoMar Ltd.

20 Jun 2011

Randox launches automated laboratory assay for Heart-type Fatty Acid Binding Protein

Randox Laboratories, the international clinical diagnostics company, has today launched an automated laboratory assay for Heart-type Fatty Acid Binding Protein (H-FABP), to improve the diagnosis and management of patients with suspected acute coronary syndrome (ACS).

From Randox Laboratories Ltd. 20 Jun 2011

Medidata to acquire Clinical Force

Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today announced that it has entered into a definitive agreement to acquire Clinical Force, a pioneer in providing SaaS-based clinical trial management systems (CTMS), for undisclosed proceeds.

20 Jun 2011

Endo Pharmaceuticals, Jubilant achieve milestone in cancer drug development program

Jubilant Biosys Ltd., Bengaluru based subsidiary of Jubilant Life Sciences Ltd., and Endo Pharmaceuticals, of Chadds Ford, Pa, U.S.A., announced today that they have achieved a late stage discovery milestone in their joint program focused on cancer.

20 Jun 2011

Pancreatic Cancer Action Network calls on federal government to make research a national priority

The Pancreatic Cancer Action Network is calling on the federal government to make pancreatic cancer research a national priority, as the incidence and death rates for the fourth leading cause of cancer death in our country continue to increase according to "Cancer Facts & Figures 2011," a report released today by the American Cancer Society.

18 Jun 2011

GenMark prices public offering of common stock

GenMark Diagnostics, Inc., a molecular diagnostics company focused on developing and commercializing proprietary eSensor detection technology, announced today the pricing of a public offering of 7,065,600 shares of its common stock at a price to the public of $4.25 per share.

17 Jun 2011

'Ultrawideband' technology for real-time health diagnosis

New research by electrical engineers at Oregon State University has confirmed that an electronic technology called "ultrawideband" could hold part of the solution to an ambitious goal in the future of medicine - health monitoring with sophisticated "body-area networks."

17 Jun 2011

Roche RTCA HT Instrument allows fully-automated impedance screens for GPCRs

Label-free technologies have entered the stage of cellular drug discovery and high-throughput screening (HTS). For the measurement of G protein-coupled receptor (GPCR) activation electrical impedance represents an excellent universal readout technology, since different signaling pathways can be measured in one assay format using recombinant as well as primary cells.

17 Jun 2011

Diagnostics News and Research

Biosign grants 3,115,000 stock options at $0.92 per share

Veredus Labs develops ‘Lab-on-Chip’ to detect and differentiate several food-borne pathogens, including Escherichia coli

Veredus Lab-on-Chip application can diagnose and differentiate food-borne pathogens

PNAS publishes Roche manuscript on generation of human bispecific IgG antibodies

Avedro receives Gold MDEA award for Vedera System

Biotest, Abbott partner to develop and commercialize BT-061 for autoimmune diseases

NextGen launches first CSF multiplex protein assay for detecting CNS diseases

African-Americans more likely to die from thyroid cancer than whites

Rheonix, Mayo Clinic partner for genotyping test to assist warfarin sensitivity

Mayo Clinic announces collaboration on genotyping test for Warfarin sensitivity

Endo acquires American Medical Systems for $2.9 billion in cash

Genetic Technologies introduces BREVAGen genetic test for assessing non-familial breast cancer risk

Neogen announces acquisition of VeroMara

Randox launches automated laboratory assay for Heart-type Fatty Acid Binding Protein

Medidata to acquire Clinical Force

Endo Pharmaceuticals, Jubilant achieve milestone in cancer drug development program

Pancreatic Cancer Action Network calls on federal government to make research a national priority

GenMark prices public offering of common stock

'Ultrawideband' technology for real-time health diagnosis

Roche RTCA HT Instrument allows fully-automated impedance screens for GPCRs

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News